The economic cost of delirium : A systematic review and quality assessment

© 2021 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association..

INTRODUCTION: This review aims to systematically identify and appraise the methodological quality of claims on the cost of delirium; and discuss challenges and opportunities for improvements in the precision of the estimates.

METHODS: Searches of scientific papers and gray literature were performed up until June 2020. The Larg and Moss checklist was used to assess the methodological quality of the included studies.

RESULTS: After deduplication, the search identified 317 potentially relevant articles, of which 17 articles were eligible for inclusion. After adjusting for inflation and common currency, the cost of delirium ranged between $806 and $24,509 (in 2019 US$).

DISCUSSION: This review found significant variation among the cost estimates and methodological quality. There has been limited focus on dementia as a sequela of delirium in terms of economic implications, but recent evidence suggests cost implications of delirium may be 52% higher when dementia is considered.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:17

Enthalten in:

Alzheimer's & dementia : the journal of the Alzheimer's Association - 17(2021), 6 vom: 06. Juni, Seite 1026-1041

Sprache:

Englisch

Beteiligte Personen:

Kinchin, Irina [VerfasserIn]
Mitchell, Eileen [VerfasserIn]
Agar, Meera [VerfasserIn]
Trépel, Dominic [VerfasserIn]

Links:

Volltext

Themen:

Cost
Cost of illness
Delirium
Economic impact
Journal Article
Methodology
Quality assessment
Systematic Review
Systematic review

Anmerkungen:

Date Completed 12.11.2021

Date Revised 12.11.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1002/alz.12262

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM320424359